Logo image of AHG

AKSO HEALTH GROUP (AHG) Stock Fundamental Analysis

NASDAQ:AHG - Nasdaq - US98422P1084 - ADR - Currency: USD

1.3  -0.03 (-2.26%)

Fundamental Rating

3

Overall AHG gets a fundamental rating of 3 out of 10. We evaluated AHG against 108 industry peers in the Health Care Providers & Services industry. No worries on liquidiy or solvency for AHG as it has an excellent financial health rating, but there are worries on the profitability. AHG does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year AHG has reported negative net income.
AHG had a positive operating cash flow in the past year.
AHG had negative earnings in each of the past 5 years.
In multiple years AHG reported negative operating cash flow during the last 5 years.
AHG Yearly Net Income VS EBIT VS OCF VS FCFAHG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

1.2 Ratios

The Return On Assets of AHG (-6.66%) is worse than 66.36% of its industry peers.
AHG has a Return On Equity (-6.84%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -6.66%
ROE -6.84%
ROIC N/A
ROA(3y)-13.47%
ROA(5y)-47.73%
ROE(3y)-53.44%
ROE(5y)-101.9%
ROIC(3y)N/A
ROIC(5y)N/A
AHG Yearly ROA, ROE, ROICAHG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150 -200

1.3 Margins

AHG's Gross Margin of 5.06% is on the low side compared to the rest of the industry. AHG is outperformed by 81.31% of its industry peers.
The Profit Margin and Operating Margin are not available for AHG so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 5.06%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AHG Yearly Profit, Operating, Gross MarginsAHG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

More info and screens

8

2. Health

2.1 Basic Checks

Compared to 1 year ago, AHG has an improved debt to assets ratio.
AHG Yearly Shares OutstandingAHG Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M
AHG Yearly Total Debt VS Total AssetsAHG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

AHG has an Altman-Z score of 87.53. This indicates that AHG is financially healthy and has little risk of bankruptcy at the moment.
AHG has a better Altman-Z score (87.53) than 100.00% of its industry peers.
AHG has a debt to FCF ratio of 1.48. This is a very positive value and a sign of high solvency as it would only need 1.48 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.48, AHG belongs to the top of the industry, outperforming 87.85% of the companies in the same industry.
AHG has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
AHG's Debt to Equity ratio of 0.01 is amongst the best of the industry. AHG outperforms 82.24% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 1.48
Altman-Z 87.53
ROIC/WACCN/A
WACCN/A
AHG Yearly LT Debt VS Equity VS FCFAHG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

2.3 Liquidity

A Current Ratio of 39.52 indicates that AHG has no problem at all paying its short term obligations.
With an excellent Current ratio value of 39.52, AHG belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
AHG has a Quick Ratio of 39.46. This indicates that AHG is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of AHG (39.46) is better than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 39.52
Quick Ratio 39.46
AHG Yearly Current Assets VS Current LiabilitesAHG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

0

3. Growth

3.1 Past

AHG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -220.05%.
The Revenue for AHG has decreased by -81.71% in the past year. This is quite bad
The Revenue has been decreasing by -8.18% on average over the past years.
EPS 1Y (TTM)-220.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%6.8%
Revenue 1Y (TTM)-81.71%
Revenue growth 3YN/A
Revenue growth 5Y-8.18%
Sales Q2Q%16.16%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AHG Yearly Revenue VS EstimatesAHG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
AHG Yearly EPS VS EstimatesAHG Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1 2 3 4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AHG. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AHG Price Earnings VS Forward Price EarningsAHG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

AHG's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 383.7
EV/EBITDA N/A
AHG Per share dataAHG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 0.2 0.3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AHG!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AKSO HEALTH GROUP

NASDAQ:AHG (2/21/2025, 8:00:29 PM)

1.3

-0.03 (-2.26%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)12-04 2023-12-04
Earnings (Next)N/A N/A
Inst Owners0.08%
Inst Owner Change15.99%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap518.47M
AnalystsN/A
Price TargetN/A
Short Float %0.06%
Short Ratio0.33
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.6
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 214.75
P/FCF 383.7
P/OCF 383.7
P/B 3.75
P/tB 3.75
EV/EBITDA N/A
EPS(TTM)-0.03
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFY0.26%
OCF(TTM)0
OCFY0.26%
SpS0.01
BVpS0.35
TBVpS0.35
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.66%
ROE -6.84%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 5.06%
FCFM 55.97%
ROA(3y)-13.47%
ROA(5y)-47.73%
ROE(3y)-53.44%
ROE(5y)-101.9%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 1.48
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 39.52
Quick Ratio 39.46
Altman-Z 87.53
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-220.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%6.8%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-81.71%
Revenue growth 3YN/A
Revenue growth 5Y-8.18%
Sales Q2Q%16.16%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y39.59%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y141.58%
FCF growth 3Y-48.79%
FCF growth 5YN/A
OCF growth 1Y141.58%
OCF growth 3Y-48.79%
OCF growth 5YN/A